The researchers grew the modified cells in the lab to increase their numbers and then injected them into an animal model where they again
killed human myeloma cells.
Not exact matches
The researchers then tested the capacity of the modified cells to
kill human multiple
myeloma cells in laboratory studies and an animal model.
The researchers modified a type of
human immune cell — called T lymphocytes, or T cells — to target a molecule called CS1, which is found on more than 95 percent of
myeloma cells, and to
kill the cells.